Gene: LRRC46
Official Full Name: leucine rich repeat containing 46provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23732 | LRRC46 Knockout cell line (HeLa) | Human | LRRC46 | 1:3~1:6 | Negative | Online Inquiry |
KO23733 | LRRC46 Knockout cell line (HCT 116) | Human | LRRC46 | 1:2~1:4 | Negative | Online Inquiry |
KO23734 | LRRC46 Knockout cell line (HEK293) | Human | LRRC46 | 1:3~1:6 | Negative | Online Inquiry |
KO23735 | LRRC46 Knockout cell line (A549) | Human | LRRC46 | 1:3~1:4 | Negative | Online Inquiry |
LRRC46 Gene Knockout Cell Lines are genetically engineered cell lines in which the LRRC46 gene has been selectively disrupted or "knocked out." This innovative biological product is designed for researchers aiming to investigate the role of LRRC46 in various biological processes, including cell signaling, immune response, and differentiation. By providing a robust model for studying the absence of this gene, these knockout cell lines facilitate a deeper understanding of its functional implications in both physiological and pathological contexts.
The key function of LRRC46 Gene Knockout Cell Lines lies in their ability to elucidate the mechanisms by which gene expression influences cellular behavior. By creating a homogeneous population of cells lacking LRRC46, researchers can perform comparative analyses with wild-type cell lines, thereby examining changes in cellular pathways, gene expression profiles, and physiological responses. This product enhances mechanistic studies by providing a clear lens through which to observe the absence of LRRC46's crosstalk in key signaling pathways.
The scientific importance of LRRC46 Gene Knockout Cell Lines is underscored by their applications in both fundamental research and clinical investigations. In disease model studies, these knockout lines can be instrumental in understanding the role of LRRC46 in cancer biology and immune disorders, paving the way for potential therapeutic targets or biomarker identification. Furthermore, they can serve as valuable tools in drug discovery, enabling high-throughput screening of compounds that may modulate LRRC46-related pathways.
When compared to alternative products, LRRC46 Gene Knockout Cell Lines offer several advantages. Their generation utilizes state-of-the-art CRISPR/Cas9 technology, ensuring precise gene editing with minimal off-target effects. Additionally, these cell lines are extensively validated for phenotypic stability and reproducibility, providing researchers with reliable models for experimental use. The ease of accessibility and the comprehensive support from our company further serve to streamline the research process.
Researchers and clinicians alike will find LRRC46 Gene Knockout Cell Lines of great value as they enable groundbreaking discoveries through innovative methodologies. By having access to these targeted models, users can enhance their understanding of complex biological questions and drive forward translational research efforts.
Our company prides itself on its expertise in providing high-quality genetic tools and cell lines, backed by extensive research and development. We are committed to delivering products that empower the scientific community and accelerate discovery in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.